MedTrace Logo

Study the Content of the HBV DNA in Liver Biopsy in the Patients Chronic Hepatitis Delta

NCT04170452 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2019-11-21

No results posted yet for this study

Summary

Study the content of the HBV DNA in liver biopsy in the patients with the Chronic Hepatitis Delta in absence of the HBV DNA in the blood plasma

Conditions

Interventions

PROCEDURE

liver biopsy

Pre-procedure assessment of the liver with ultrasound should be performed for planning positioning and needle entrance point. Supine, oblique, or total left lateral decubitus are the possible positioning of the patient - it is important to make sure that the patient is comfortable and can remain still in that position. Assessing if the procedure will be performed under breath held and practice this with the patient. Marking of the entrance point on the skin is advised to aid the skin cleaning and dressing. A time-out should be performed by this stage. Skin site is prepped and draped to ensure asepsis. Ocal anaesthesia is infiltrated under the skin abdominal wall/intercostal space until the liver capsule. Entrance point is created with a scalpel. Using the freehand technique the needle is advanced under ultrasound guidance during the entire course of the biopsy. The needle tip must always cross the capsule prior to deploying the cutting device.

Sponsors & Collaborators

  • Tokhirbek Dolimov

    lead OTHER_GOV

Principal Investigators

  • Nariman Gulyamov, DSci · Research institute of epidemiology, microbiology and infectious diseases

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-10-10
Primary Completion
2020-06-01
Completion
2020-06-01

Countries

  • Uzbekistan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04170452 on ClinicalTrials.gov